Mitotic Bypass Via An Occult Cell Cycle Phase Following DNA Topoisomerase II Inhibition In p53 Functional Human Tumor Cells

• Published in: Cell cycle (Georgetown, Tex.) Tex.), 2007-08, Vol.6 (16), p.2071-2081
• Main Authors: Smith, Paul J., Marquez, Nuria, Wiltshire, Marie, Chappell, Sally, Njoh, Kerenza, Campbell, Lee, Khan, Imtiaz A., Silvestre, Oscar, Errington, Rachel J.
• Format: Article
• Language: English
• Subjects: Binding; Biology; Bioscience; Calcium; Cancer; Cell; Cell Cycle - drug effects; Cell Cycle - genetics; Cell Cycle - physiology; Cell Line, Tumor; Chromosomal Instability - drug effects; Cycle; Cyclin B - genetics; Cyclin B - metabolism; Cyclin B1; Cytoplasm - metabolism; DNA Topoisomerases, Type II - metabolism; Flow Cytometry; Green Fluorescent Proteins - genetics; Green Fluorescent Proteins - metabolism; Humans; Landes; Microscopy, Fluorescence; Mitosis - drug effects; Mitosis - genetics; Mitosis - physiology; Organogenesis; Piperazines - pharmacology; Proteins; Topoisomerase II Inhibitors; Transfection; Tumor Suppressor Protein p53 - genetics; Tumor Suppressor Protein p53 - metabolism
• ISSN: 1538-4101; 1551-4005
• DOI: 10.4161/cc.6.16.4585

Cell cycle checkpoints guard against the inappropriate commitment to critical cell events such as mitosis. The bisdioxopiperazine ICRF-193, a catalytic inhibitor of DNA topoisomerase II, causes a reversible stalling of the exit of cells from G2 at the decatenation checkpoint (DC) and can generate tetraploidy via the compromising of chromosome segregation and mitotic failure. We have addressed an alternative origin - endocycle entry - for the tetraploidisation step in ICRF-193 exposed cells. Here we show that DC-proficient p53-functional tumour cells can undergo a transition to tetraploidy and subsequent aneuploidy via an initial bypass of mitosis and the mitotic spindle checkpoint. DC-deficient SV40-tranformed cells move exclusively through mitosis to tetraploidy. In p53-functional tumour cells, escape through mitosis is enhanced by dominant negative p53 co-expression. The mitotic bypass transition phase (termed G2endo) disconnects cyclin B1 degradation from nuclear envelope breakdown and allows cells to evade the action of Taxol. G2endo constitutes a novel and alternative cell cycle phase - lasting some 8 h - with distinct molecular motifs at its boundaries for G2 exit and subsequent entry into a delayed G1 tetraploid state. The results challenge the paradigm that checkpoint breaching leads directly to abnormal ploidy states via mitosis alone. We further propose that the induction of bypass could: facilitate the covert development of tetraploidy in p53 functional cancers, lead to a misinterpretation of phase allocation during cell cycle arrest and contribute to tumour cell drug resistance.